CN104983954A - Medicament for treating cervical hypertrophy - Google Patents
Medicament for treating cervical hypertrophy Download PDFInfo
- Publication number
- CN104983954A CN104983954A CN201510481410.7A CN201510481410A CN104983954A CN 104983954 A CN104983954 A CN 104983954A CN 201510481410 A CN201510481410 A CN 201510481410A CN 104983954 A CN104983954 A CN 104983954A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- medicament
- cervical hypertrophy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating cervical hypertrophy. The medicament for treating cervical hypertrophy is prepared from the following materials, by weight, 1-10 parts of stylophorum lasiocarpum(oliv.)fedde, 10-20 parts of selaginella delicatula, 10-20 parts of root of common peony, 1-10parts of liquorice, 10-20 parts of bunge corydalis herb, 1-10 parts of medicinal cyathula roots, 1-10 parts of morinda officinalis, 10-20 parts of ailantus endocuticle, 1-10 parts of cicada slough, 10-20 parts of etlingera yunnanense, 1-10 parts of finetooth holly, 10-20 parts of phtheirospermum japonicum, 1-10 parts of monochoria korsakowii, 10-20 parts of alternanthera sessilis, 1-10 parts of calendula roots, 5-15 parts of Chinese tamarisk, 1-10 parts of indigoplant fruit, 5-15 parts of early lilac, 10-20 parts of shrubby woodfordia roots and flowers, 1-10 parts of buckeye and 10-20 parts of white oyster-cap fungi. The medicament for treating cervical hypertrophy has an evident effect in cervical hypertrophy treatment and is worthy of clinical application and popularization.
Description
The divisional application of the patent of " a kind of medicament for the treatment of cervical hypertrophy " that the present invention is application number is 201510063401.6, the applying date, to be February 6, denomination of invention in 2015 be.
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of cervical hypertrophy.
Background technology
Cervical hypertrophy is due to pathogenic infection cervical mucosals such as mycoplasma, chlamydia, antibacterial, viruses, such that cervix uteri is congested, edema, caused by cervix gland and interstitial generation hypertrophy.Uterine cavity blood stasis, ovarian dysfunction also can cause cervical hypertrophy.Its main clinic symptoms comprises that vaginal secretions increases, waist and sacrum pain, lower abdomen pendant rises, sexual life is hemorrhage.Delay the state of an illness or malpractice possibility up concurrent endometritis, fallopian tube adhesion, oophoritis etc., severe patient can cause sterility and infertility or cervical cancer, affects normal physiological period and family life.
Doctor trained in Western medicine takes Drug therapy or naturopathy for the treatment of cervical hypertrophy more.Drug therapy gives antibiotic medicine more, such as Compound Tinidazole medicine film and policresulen class medicine etc.; Naturopathy comprises electricity and presses treatment, cold therapy, laser therapy, micro-wave therapeutic etc.The former easily causes the side effect such as drug resistance, hepar damnification, and latter needs special instrument and equipment and professional operator, and may cause that cervical canal is narrow after treatment, adhesion etc.And the traditional Chinese medical science is mainly through determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, imposes the therapies such as invigorating the spleen and benefiting QI, nourishing kidney yin, clearing away heat-damp and promoting diuresis more, and have no side effect, compare doctor trained in Western medicine more safe and reliable.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of cervical hypertrophy.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of cervical hypertrophy, it is made up of the material of following weight portion: Herba Stylophori Lasiocapi 1-10 part, selaginella delicatula Alston 10-20 part, Radix Paeoniae Rubra 10-20 part, Radix Glycyrrhizae 1-10 part, Herba Corydalis Bungeanae 10-20 part, Radix Cyathulae 1-10 part, Radix Morindae Officinalis 1-10 part, Cortex toonae sinensis radicis 10-20 part, Periostracum Cicadae 1-10 part, sand Fructus Foeniculi 10-20 part, Folium ilicis serratae 1-10 part, Herba Phtheirospermi Japonici 10-20 part, Herba Monochoriae Korsakowii 1-10 part, close flowers and plants 10-20 part, Calendula arvensis L. 1-10 part, Ramulus et Folium Tamaricis 5-15 part, Fructus polygoni tinctorii 1-10 part, Syringa oblata Lindl. 5-15 part, Flos Woodfordiae Fruticosae 10-20 part, Semen Aesculi 1-10 part, Herba Parnassiae foliosae 10-20 part.
Preferably, the medicament for the treatment of cervical hypertrophy of the present invention is made up of the material of following weight portion: Herba Stylophori Lasiocapi 8 parts, selaginella delicatula Alston 15 parts, Radix Paeoniae Rubra 15 parts, 8 parts, Radix Glycyrrhizae, Herba Corydalis Bungeanae 15 parts, Radix Cyathulae 6 parts, Radix Morindae Officinalis 5 parts, Cortex toonae sinensis radicis 15 parts, Periostracum Cicadae 8 parts, 15 parts, sand Fructus Foeniculi, Folium ilicis serratae 5 parts, Herba Phtheirospermi Japonici 12 parts, Herba Monochoriae Korsakowii 6 parts, close flowers and plants 12 parts, Calendula arvensis L. 10 parts, Ramulus et Folium Tamaricis 10 parts, Fructus polygoni tinctorii 5 parts, Syringa oblata Lindl. 10 parts, Flos Woodfordiae Fruticosae 15 parts, Semen Aesculi 8 parts, Herba Parnassiae foliosae 12 parts.
More preferably, described medicament can be tablet, dispersible tablet, capsule, soft capsule, ointment or suppository.
The present invention also provides the purposes of compositions in the medicine of preparation treatment cervical hypertrophy, described compositions is made up of the material of following weight portion: Herba Stylophori Lasiocapi 1-10 part, selaginella delicatula Alston 10-20 part, Radix Paeoniae Rubra 10-20 part, Radix Glycyrrhizae 1-10 part, Herba Corydalis Bungeanae 10-20 part, Radix Cyathulae 1-10 part, Radix Morindae Officinalis 1-10 part, Cortex toonae sinensis radicis 10-20 part, Periostracum Cicadae 1-10 part, sand Fructus Foeniculi 10-20 part, Folium ilicis serratae 1-10 part, Herba Phtheirospermi Japonici 10-20 part, Herba Monochoriae Korsakowii 1-10 part, close flowers and plants 10-20 part, Calendula arvensis L. 1-10 part, Ramulus et Folium Tamaricis 5-15 part, Fructus polygoni tinctorii 1-10 part, Syringa oblata Lindl. 5-15 part, Flos Woodfordiae Fruticosae 10-20 part, Semen Aesculi 1-10 part, Herba Parnassiae foliosae 10-20 part.
Preferably, described compositions is made up of the material of following weight portion: Herba Stylophori Lasiocapi 8 parts, selaginella delicatula Alston 15 parts, Radix Paeoniae Rubra 15 parts, 8 parts, Radix Glycyrrhizae, Herba Corydalis Bungeanae 15 parts, Radix Cyathulae 6 parts, Radix Morindae Officinalis 5 parts, Cortex toonae sinensis radicis 15 parts, Periostracum Cicadae 8 parts, 15 parts, sand Fructus Foeniculi, Folium ilicis serratae 5 parts, Herba Phtheirospermi Japonici 12 parts, Herba Monochoriae Korsakowii 6 parts, close flowers and plants 12 parts, Calendula arvensis L. 10 parts, Ramulus et Folium Tamaricis 10 parts, Fructus polygoni tinctorii 5 parts, Syringa oblata Lindl. 10 parts, Flos Woodfordiae Fruticosae 15 parts, Semen Aesculi 8 parts, Herba Parnassiae foliosae 12 parts.
More preferably, described medicine can be tablet, dispersible tablet, capsule, soft capsule, ointment or suppository.
In the present compositions, selaginella delicatula Alston, Herba Parnassiae foliosae, Fructus polygoni tinctorii are monarch drug; Herba Stylophori Lasiocapi, Radix Paeoniae Rubra, Herba Corydalis Bungeanae, Radix Morindae Officinalis, Cortex toonae sinensis radicis, sand Fructus Foeniculi, Syringa oblata Lindl. are ministerial drug; Radix Cyathulae, Periostracum Cicadae, Folium ilicis serratae, Herba Phtheirospermi Japonici, Herba Monochoriae Korsakowii, close flowers and plants, Calendula arvensis L., Ramulus et Folium Tamaricis, Flos Woodfordiae Fruticosae, Semen Aesculi are adjuvant drug; Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, for making medicine.
Medicament of the present invention is turbid based on dampnessization, resolving depression of regulating the flow of vital energy, be aided with heat-clearing and toxic substances removing, QI invigorating invigorating middle warmer, spleen reinforcing is soothing the liver, removing dampness leukorrhagia stopping, eliminating evil dehumidifying, warming the meridian can warm up liver, and have effect of certain sterilizing and itch-relieving, treatment cervical hypertrophy Be very effective, clinic application and popularization.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modification that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
The preparation of embodiment medicament of the present invention
For suppository, the step of preparation process of medicament of the present invention is as follows:
(1) Herba Stylophori Lasiocapi 80 grams, selaginella delicatula Alston 150 grams, Radix Paeoniae Rubra 150 grams, 80 grams, Radix Glycyrrhizae, Herba Corydalis Bungeanae 150 grams, Radix Cyathulae 60 grams, Radix Morindae Officinalis 50 grams, Cortex toonae sinensis radicis 150 grams, Periostracum Cicadae 80 grams, 150 grams, sand Fructus Foeniculi, Folium ilicis serratae 50 grams, Herba Phtheirospermi Japonici 120 grams, Herba Monochoriae Korsakowii 60 grams, close flowers and plants 120 grams, Calendula arvensis L. 100 grams, Ramulus et Folium Tamaricis 100 grams, Fructus polygoni tinctorii 50 grams, Syringa oblata Lindl. 100 grams, Flos Woodfordiae Fruticosae 150 grams, Semen Aesculi 80 grams, Herba Parnassiae foliosae 120 grams is taken;
(2) Herba Parnassiae foliosae, Radix Cyathulae, Ramulus et Folium Tamaricis are broken into smalls, cross 120 mesh sieves, for subsequent use;
(3) Herba Stylophori Lasiocapi, Radix Paeoniae Rubra, Radix Glycyrrhizae, selaginella delicatula Alston, Herba Corydalis Bungeanae, Folium ilicis serratae, Periostracum Cicadae, sand Fructus Foeniculi, Herba Monochoriae Korsakowii, Calendula arvensis L., Syringa oblata Lindl., Flos Woodfordiae Fruticosae, Radix Morindae Officinalis, Cortex toonae sinensis radicis, Herba Phtheirospermi Japonici, close flowers and plants, Fructus polygoni tinctorii, Semen Aesculi are put into container to add water 10 liters and soak 10 hours, then heat 3 hours under the condition of backflow, filter, make filtrate evaporate to dryness, pulverize;
(4) combining step (2) and (3) gains, add in the oleum sapii substrate of 500 grams, heating and melting, fully stir evenly, in impouring mould, mould is first coated with one deck lubricant, lubricant is the alcohol mixeding liquid of glycerol and concentration expressed in percentage by volume 95%, mixed proportion is the ethanol of 95% of 1g glycerol: 5ml, after cooling, to prune spilling part with cutter, opening mold, released by suppository, packaging, obtains required drug suppository.Obtained 100 suppositorys.
The effect of experimental example pharmaceutical treatment cervical hypertrophy of the present invention
1, physical data selects cervical hypertrophy patient 80 example, is divided into observation group 50 example and matched group 30 example.Observation group's patient age between 21-48 year, 35.6 years old mean age; Matched group patient age between 20-45 year, 32.5 years old mean age.All patients all get rid of cervical cancer, acute genital disease and systemic disease.According to table 1, symptom score is carried out to two groups of patients, wherein average 6.24 ± 1.58 points of observation group, average 5.92 ± 1.87 points of matched group before treatment.Through t check analysis, the age of two groups of patients and symptom score there are no significant difference (p>0.05).
Table 1 Symptoms index
2,3-7 days after method clean period, cleans pudendum before sleeping every night.The auxiliary drug delivery instrument of observation group's use or 1 suppository of the present invention utilizing sanitary finger-cot for holding embodiment to be prepared are delivered to vagina depths, 1 times/day.Matched group uses tinidazole suppositories (Zhengzhou Yonghe Pharmaceutical Co), 1 times/day.Within continuous 7 days, be a course for the treatment of, 2 totally 14 days courses for the treatment of of medication, period prohibitive life.
3, after 2 courses for the treatment of of evaluation index, again carry out symptom score according to table 1, and calculate therapeutic index and effective percentage.
Recovery from illness: therapeutic index >=90%; Effective: therapeutic index is 60%-89%; Take a turn for the better: therapeutic index is 20%-59%; Invalid: therapeutic index < 20%.Wherein:
Score value × 100% before therapeutic index=(before treatment the rear score value of score value-treatment)/treatment
Effective percentage=(cure+effective+take a turn for the better) number of cases/total number of cases × 100%
4, statistical method adopts statistics software SPSS17.0 to carry out data analysis.Measurement data with
represent, adopt t inspection; Enumeration data adopts x
2inspection.With P < 0.05 for difference has statistical significance.
5, result
After treatment, observation group's symptom score is 1.02 ± 0.95 points, and matched group symptom score is 2.50 ± 1.96 points, through t check analysis, two groups have significant difference.This shows that observation group's symptom takes a turn for the better and is better than matched group, and medicament of the present invention has significant advantage in treatment cervical hypertrophy.
Table 2 is below shown in two groups of efficient interpretations of result.Through x
2inspection, the effective percentage of two groups of patients after treatment has significant difference.
A table 2 liang group effective percentage compares
Note: compare with matched group, * p<0.05.
Claims (3)
1. the purposes of compositions in the medicine of preparation treatment cervical hypertrophy, it is characterized in that described compositions is made up of the material of following weight portion: Herba Stylophori Lasiocapi 1-10 part, selaginella delicatula Alston 10-20 part, Radix Paeoniae Rubra 10-20 part, Radix Glycyrrhizae 1-10 part, Herba Corydalis Bungeanae 10-20 part, Radix Cyathulae 1-10 part, Radix Morindae Officinalis 1-10 part, Cortex toonae sinensis radicis 10-20 part, Periostracum Cicadae 1-10 part, sand Fructus Foeniculi 10-20 part, Folium ilicis serratae 1-10 part, Herba Phtheirospermi Japonici 10-20 part, Herba Monochoriae Korsakowii 1-10 part, close flowers and plants 10-20 part, Calendula arvensis L. 1-10 part, Ramulus et Folium Tamaricis 5-15 part, Fructus polygoni tinctorii 1-10 part, Syringa oblata Lindl. 5-15 part, Flos Woodfordiae Fruticosae 10-20 part, Semen Aesculi 1-10 part, Herba Parnassiae foliosae 10-20 part.
2. purposes according to claim 1, wherein said compositions is made up of the material of following weight portion: Herba Stylophori Lasiocapi 8 parts, selaginella delicatula Alston 15 parts, Radix Paeoniae Rubra 15 parts, 8 parts, Radix Glycyrrhizae, Herba Corydalis Bungeanae 15 parts, Radix Cyathulae 6 parts, Radix Morindae Officinalis 5 parts, Cortex toonae sinensis radicis 15 parts, Periostracum Cicadae 8 parts, 15 parts, sand Fructus Foeniculi, Folium ilicis serratae 5 parts, Herba Phtheirospermi Japonici 12 parts, Herba Monochoriae Korsakowii 6 parts, close flowers and plants 12 parts, Calendula arvensis L. 10 parts, Ramulus et Folium Tamaricis 10 parts, Fructus polygoni tinctorii 5 parts, Syringa oblata Lindl. 10 parts, Flos Woodfordiae Fruticosae 15 parts, Semen Aesculi 8 parts, Herba Parnassiae foliosae 12 parts.
3. purposes according to claim 1 and 2, wherein said medicine can be tablet, dispersible tablet, capsule, soft capsule, ointment or suppository.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510063401.6A CN104666651B (en) | 2015-02-06 | 2015-02-06 | A kind of medicament for the treatment of cervical hypertrophy |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510063401.6A Division CN104666651B (en) | 2015-02-06 | 2015-02-06 | A kind of medicament for the treatment of cervical hypertrophy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104983954A true CN104983954A (en) | 2015-10-21 |
Family
ID=53302587
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510481410.7A Pending CN104983954A (en) | 2015-02-06 | 2015-02-06 | Medicament for treating cervical hypertrophy |
| CN201510063401.6A Expired - Fee Related CN104666651B (en) | 2015-02-06 | 2015-02-06 | A kind of medicament for the treatment of cervical hypertrophy |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510063401.6A Expired - Fee Related CN104666651B (en) | 2015-02-06 | 2015-02-06 | A kind of medicament for the treatment of cervical hypertrophy |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN104983954A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110302304A (en) * | 2019-08-12 | 2019-10-08 | 南京依美生物科技有限公司 | A kind of gynecological gel preparation and preparation method thereof for treating cervical hypertrophy |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101791377A (en) * | 2010-04-12 | 2010-08-04 | 汤永顺 | Traditional Chinese medicine preparation for post-operation rehabilitation of cervicitis and cervical hypertrophy |
-
2015
- 2015-02-06 CN CN201510481410.7A patent/CN104983954A/en active Pending
- 2015-02-06 CN CN201510063401.6A patent/CN104666651B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101791377A (en) * | 2010-04-12 | 2010-08-04 | 汤永顺 | Traditional Chinese medicine preparation for post-operation rehabilitation of cervicitis and cervical hypertrophy |
Non-Patent Citations (2)
| Title |
|---|
| 林茶明: "宫颈糜烂、宫颈肥大的药物治疗", 《江西医药》 * |
| 郭林茹等: "清热除湿化瘀汤结合微波治疗慢性盆腔炎80例临床研究", 《河北中医》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110302304A (en) * | 2019-08-12 | 2019-10-08 | 南京依美生物科技有限公司 | A kind of gynecological gel preparation and preparation method thereof for treating cervical hypertrophy |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104666651A (en) | 2015-06-03 |
| CN104666651B (en) | 2015-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101433654B (en) | Chinese medicine preparation for treating women's chronic pelvic inflammatory disease and preparation method thereof | |
| CN105535715A (en) | Traditional Chinese medicine skin-wash liquid for treating hot and damp eczema | |
| CN101011544A (en) | Gout rapid recovery pill(capsule) and preparation technique thereof | |
| CN102743665B (en) | Chinese medicinal composition for promoting healing after boneblast, as well as preparation method and application thereof | |
| CN102961483B (en) | Traditional Chinese medicine composition for treating pain in waist and lower extremities and preparation method thereof | |
| CN103463582B (en) | A kind of pharmaceutical composition treating pelvic inflammatory disease and its production and use | |
| CN104666651B (en) | A kind of medicament for the treatment of cervical hypertrophy | |
| CN102579677B (en) | Chinese medicinal composition for treating brain glioma | |
| CN102274417A (en) | Chinese patent medicament for treating aplastic anemia | |
| CN104873706A (en) | Traditional Chinese medicine composition for treating uterine cold infertility | |
| CN104706953A (en) | Traditional Chinese medicine preparation for treating chronic cervicitis | |
| CN103705846A (en) | Traditional Chinese medicine preparation for treating ovarian cyst | |
| CN103611027B (en) | The pharmaceutical composition of a kind of clinical prevention, nursing and treatment trichomonal vaginitis | |
| CN102973876B (en) | Drug for treating pathological leukorrhagia | |
| CN105770400A (en) | Traditional Chinese medicine composition for treating puerperal infection | |
| CN101637599B (en) | Chinese medicinal composition for removing haemostasis in female genital system | |
| CN110841043A (en) | Traditional Chinese medicine composition of fallopian tube infertility plaster | |
| CN101366878A (en) | Traditional Chinese medicine for female acyesis and aphoria and preparation method thereof | |
| CN104644956A (en) | Traditional Chinese medicine composition for treating cold congealing and blood stasis type dysmenorrheal and preparation method thereof | |
| CN103110722B (en) | Traditional Chinese medicine for treating chronic pelvic inflammatory disease and preparation method thereof | |
| CN103520424A (en) | Traditional Chinese medicine preparation for treating periodontitis | |
| CN1279953C (en) | Mediciation for curing female disease | |
| CN105535674A (en) | A medicine for treating chronic cervicitis | |
| CN104758627B (en) | It is a kind of to treat the Chinese medicine preparation for not producing type chronic cervicitis | |
| CN102512637B (en) | Medicine for treating special chronic sinusitis of patients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Huang Guoyong Inventor before: Li Zhigang |
|
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20170308 Address after: 214000 Jiangsu city of Wuxi Province East Pavilion Street Xishan District Yingbin Road No. 1 Applicant after: Wuxi Sani pacifies Science and Technology Ltd. Address before: 054001 Xingtai Development Zone, Hebei, South Road, No. 168 Applicant before: Li Zhigang |
|
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151021 |